共 50 条
- [21] A Phase I, Single-Ascending-Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DS-2969b, a Novel GyrB Inhibitor JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (12): : 1557 - 1565
- [23] PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY, AND TOLERABILITY OF BI 11634, A NOVEL DIRECT ORAL FACTOR XA INHIBITOR, IN A SINGLE ASCENDING DOSE STUDY JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1061 - 1061
- [26] Pharmacokinetics, pharmacodynamics, and safety of izuforant, an H4R inhibitor, in healthy subjects: A phase I single and multiple ascending dose study CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (10):
- [29] Phase I Single Ascending Dose and Food Effect Study in Healthy Adults and Phase I/IIa Multiple Ascending Dose Study in Patients with Pulmonary Tuberculosis to Assess Pharmacokinetics, Bactericidal Activity, Tolerability, and Safety of OPC-167832 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (06)
- [30] Safety, Tolerability, and Pharmacokinetics of the Mineralocorticoid Receptor Modulator AZD9977 in Healthy Men: A Phase I Multiple Ascending Dose Study CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (02): : 275 - 283